Wishart, Graham N.
Eli Lilly (United Kingdom)
4 papers on CoChat
Most cited papers
- Verified
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
Gelbert, L. M., Cai, S., Lin, X., Sanchez-Martinez, C., del Prado, M., Lallena, M. J., Torres, R., Ajamie, R. T., Wishart, G. N., Flack, R. S., et al. (2014) · Investigational New Drugs
Cancer-related Molecular PathwaysAdvanced Breast Cancer Therapies
Cited by 577
- Verified
Brain exposure of two selective dual CDK4 and CDK6 inhibitors and the antitumor activity of CDK4 and CDK6 inhibition in combination with temozolomide in an intracranial glioblastoma xenograft
Raub, T. J., Wishart, G. N., Kulanthaivel, P., Staton, B. A., Ajamie, R. T., Sawada, G. A., Gelbert, L. M., Shannon, H. E., Sanchez-Martinez, C., & De Dios, A. (2015) · Drug Metabolism and Disposition
Glioma Diagnosis and TreatmentDrug Transport and Resistance Mechanisms
Cited by 284
- Verified
Semi-mechanistic pharmacokinetic/pharmacodynamic modeling of the antitumor activity of LY2835219, a new cyclin-dependent kinase 4/6 inhibitor, in mice bearing human tumor xenografts
Tate, S. C., Cai, S., Ajamie, R. T., Burke, T., Beckmann, R. P., Chan, E. M., De Dios, A., Wishart, G. N., Gelbert, L. M., & Cronier, D. M. (2014) · Clinical Cancer Research
Advanced Breast Cancer TherapiesMathematical Biology Tumor Growth
Cited by 130
- Verified
An assessment of the central disposition of intranasally administered insulin lispro in the cerebrospinal fluid of healthy volunteers and beagle dogs
Lowe, S., Sher, E., Wishart, G., Jackson, K., Yuen, E., Brittain, C., Fong, S. C., Clarke, D. O., & Landschulz, W. H. (2017) · Drug Delivery and Translational Research
Advanced Drug Delivery SystemsAlzheimer's disease research and treatments
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free